abstract |
The new use of antagonists of the N-methyl-D-aspartate (NMDA) -receptor complex or their physiologically tolerable salts as medicaments for the prevention and treatment of chronic neurodegenerative diseases, as well as pharmaceutical agents which contain these compounds, are described. |